Related Articles
Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Suberoyl bis-hydroxamic acid activates Notch1 signaling and induces apoptosis in anaplastic thyroid carcinoma through p53